{"transactions":[{"id":4616474,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT, Surgical & IHFM"}}],"security":"Common Stock","published_at":"2026-09-11T23:15:12.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":398,"price":86.77,"value":34534.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":43926,"source":{"system":"sec-edgar","filing":"0001225208-26-007775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740963/000122520826007775/doc4.xml","form_type":"4"}},{"id":675434,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT, Surgical & IHFM"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-08-26T22:36:41.000Z","date":"2026-08-26","kind":"exercise","planned":false,"acquired":false,"shares":31800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":31800},"source":{"system":"sec-edgar","filing":"0001225208-26-007335","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007335/doc4.xml","form_type":"4"}},{"id":675433,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT, Surgical & IHFM"}}],"security":"Common Stock","published_at":"2026-08-26T22:36:41.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":30646,"price":90.9922,"value":2788546.9612,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $90.645 to $91.640. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":44324,"source":{"system":"sec-edgar","filing":"0001225208-26-007335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007335/doc4.xml","form_type":"4"}},{"id":675432,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT, Surgical & IHFM"}}],"security":"Common Stock","published_at":"2026-08-26T22:36:41.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":1154,"price":91.7614,"value":105892.6556,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $91.660 to $91.975. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":74970,"source":{"system":"sec-edgar","filing":"0001225208-26-007335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007335/doc4.xml","form_type":"4"}},{"id":675431,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT, Surgical & IHFM"}}],"security":"Common Stock","published_at":"2026-08-26T22:36:41.000Z","date":"2026-08-26","kind":"exercise","planned":false,"acquired":true,"shares":31800,"price":72.68,"value":2311224.0,"ownership":{"direct":true},"balance_after":76124,"source":{"system":"sec-edgar","filing":"0001225208-26-007335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007335/doc4.xml","form_type":"4"}},{"id":766707,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2026-05-22T20:35:58.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":84.6035,"value":126905.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $84.6002 to $84.6050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":44324,"source":{"system":"sec-edgar","filing":"0001225208-26-005576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005576/doc4.xml","form_type":"4"}},{"id":783148,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Performance Rights","published_at":"2026-05-12T20:50:35.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":13583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These Performance Rights expire on May 10, 2030."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":13583},"source":{"system":"sec-edgar","filing":"0001225208-26-005170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005170/doc4.xml","form_type":"4"}},{"id":783147,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2026-05-12T20:50:35.000Z","date":"2026-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":7538,"price":79.96,"value":602738.48,"ownership":{"direct":true},"balance_after":45824,"source":{"system":"sec-edgar","filing":"0001225208-26-005170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005170/doc4.xml","form_type":"4"}},{"id":783146,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2026-05-12T20:50:35.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":13583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":53362,"source":{"system":"sec-edgar","filing":"0001225208-26-005170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005170/doc4.xml","form_type":"4"}},{"id":787469,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Performance Rights","published_at":"2026-05-09T01:16:28.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":9675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."}],"balance_after":9675,"derivative":{"exercise_date":"2029-05-07","underlying":"Common Stock","underlying_shares":9675},"source":{"system":"sec-edgar","filing":"0001225208-26-005043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005043/doc4.xml","form_type":"4"}},{"id":787468,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-09T01:16:28.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":49100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":49100,"derivative":{"exercise_price":82.76,"exercise_date":"2027-05-07","expiration_date":"2033-05-06","underlying":"Common Stock","underlying_shares":49100},"source":{"system":"sec-edgar","filing":"0001225208-26-005043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005043/doc4.xml","form_type":"4"}},{"id":787467,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:28.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1141,"price":82.76,"value":94429.16,"ownership":{"direct":true},"balance_after":39779,"source":{"system":"sec-edgar","filing":"0001225208-26-005043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005043/doc4.xml","form_type":"4"}},{"id":787466,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:28.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":674,"price":83.2,"value":56076.8,"ownership":{"direct":true},"balance_after":40920,"source":{"system":"sec-edgar","filing":"0001225208-26-005043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005043/doc4.xml","form_type":"4"}},{"id":787465,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:28.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":9675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":41594,"source":{"system":"sec-edgar","filing":"0001225208-26-005043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005043/doc4.xml","form_type":"4"}},{"id":794456,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2026-05-04T23:29:45.000Z","date":"2026-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":282,"price":83.98,"value":23682.36,"ownership":{"direct":true},"balance_after":31919,"source":{"system":"sec-edgar","filing":"0001225208-26-004908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004908/doc4.xml","form_type":"4"}},{"id":973171,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2025-12-11T22:58:39.000Z","date":"2025-12-11","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":84.3751,"value":168750.2,"ownership":{"direct":true},"balance_after":32201,"source":{"system":"sec-edgar","filing":"0001225208-25-009873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009873/doc4.xml","form_type":"4"}},{"id":1040910,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2025-09-15T22:44:45.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":3205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on September 11, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":34201,"source":{"system":"sec-edgar","filing":"0001225208-25-007991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825007991/doc4.xml","form_type":"4"}},{"id":1057084,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2025-08-25T22:25:51.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":81.946,"value":204865.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $81.9401 to $81.9500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30996,"source":{"system":"sec-edgar","filing":"0001225208-25-007460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825007460/doc4.xml","form_type":"4"}},{"id":1137994,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2025-05-22T21:08:08.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":75.075,"value":112612.5,"ownership":{"direct":true},"balance_after":33496,"source":{"system":"sec-edgar","filing":"0001225208-25-005388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005388/doc4.xml","form_type":"4"}},{"id":1152754,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2025-05-12T23:30:34.000Z","date":"2025-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":580,"price":73.68,"value":42734.4,"ownership":{"direct":true},"balance_after":34996,"source":{"system":"sec-edgar","filing":"0001225208-25-004998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004998/doc4.xml","form_type":"4"}},{"id":1154313,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Performance Rights","published_at":"2025-05-09T23:34:15.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":9200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":9200,"derivative":{"exercise_date":"2028-05-08","underlying":"Common Stock","underlying_shares":9200},"source":{"system":"sec-edgar","filing":"0001225208-25-004944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004944/doc4.xml","form_type":"4"}},{"id":1154312,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-09T23:34:15.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":47000,"derivative":{"exercise_price":74.63,"exercise_date":"2026-05-08","expiration_date":"2032-05-07","underlying":"Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001225208-25-004944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004944/doc4.xml","form_type":"4"}},{"id":1154311,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:15.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":9200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":35576,"source":{"system":"sec-edgar","filing":"0001225208-25-004944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004944/doc4.xml","form_type":"4"}},{"id":1154310,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:15.000Z","date":"2025-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":627,"price":74.92,"value":46974.84,"ownership":{"direct":true},"balance_after":26376,"source":{"system":"sec-edgar","filing":"0001225208-25-004944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004944/doc4.xml","form_type":"4"}},{"id":1159954,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2025-05-05T23:29:29.000Z","date":"2025-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":289,"price":75.65,"value":21862.85,"ownership":{"direct":true},"balance_after":27003,"source":{"system":"sec-edgar","filing":"0001225208-25-004767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004767/doc4.xml","form_type":"4"}},{"id":1159953,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2025-05-05T23:29:29.000Z","date":"2025-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":291,"price":75.65,"value":22014.15,"ownership":{"direct":true},"balance_after":27292,"source":{"system":"sec-edgar","filing":"0001225208-25-004767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004767/doc4.xml","form_type":"4"}},{"id":1340943,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-12-06T21:56:47.000Z","date":"2024-12-06","kind":"sale","planned":false,"acquired":false,"shares":1750,"price":73.2701,"value":128222.675,"ownership":{"direct":true},"balance_after":27583,"source":{"system":"sec-edgar","filing":"0001225208-24-010631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010631/doc4.xml","form_type":"4"}},{"id":1428166,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-08-20T23:42:42.000Z","date":"2024-08-20","kind":"sale","planned":false,"acquired":false,"shares":1250,"price":69.9501,"value":87437.625,"ownership":{"direct":true},"balance_after":29333,"source":{"system":"sec-edgar","filing":"0001225208-24-008118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824008118/doc4.xml","form_type":"4"}},{"id":1519593,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-05-13T21:45:51.000Z","date":"2024-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":821,"price":86.72,"value":71197.12,"ownership":{"direct":true},"balance_after":30583,"source":{"system":"sec-edgar","filing":"0001225208-24-005981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005981/doc4.xml","form_type":"4"}},{"id":1522398,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Performance Rights","published_at":"2024-05-09T23:40:24.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":7000,"derivative":{"exercise_date":"2027-05-07","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001225208-24-005889","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005889/doc4.xml","form_type":"4"}},{"id":1522397,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-09T23:40:24.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":37200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":37200,"derivative":{"exercise_price":85.84,"exercise_date":"2025-05-07","expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":37200},"source":{"system":"sec-edgar","filing":"0001225208-24-005889","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005889/doc4.xml","form_type":"4"}},{"id":1522396,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-05-09T23:40:24.000Z","date":"2024-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":447,"price":85.09,"value":38035.23,"ownership":{"direct":true},"balance_after":31404,"source":{"system":"sec-edgar","filing":"0001225208-24-005889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005889/doc4.xml","form_type":"4"}},{"id":1522395,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-05-09T23:40:24.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":31851,"source":{"system":"sec-edgar","filing":"0001225208-24-005889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005889/doc4.xml","form_type":"4"}},{"id":1526666,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Performance Rights","published_at":"2024-05-06T23:17:52.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":false,"shares":4713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_date":"2024-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":4713},"source":{"system":"sec-edgar","filing":"0001225208-24-005701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005701/doc4.xml","form_type":"4"}},{"id":1526665,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-05-06T23:17:52.000Z","date":"2024-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2321,"price":85.25,"value":197865.25,"ownership":{"direct":true},"balance_after":24851,"source":{"system":"sec-edgar","filing":"0001225208-24-005701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005701/doc4.xml","form_type":"4"}},{"id":1526664,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-05-06T23:17:52.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":true,"shares":4713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":27172,"source":{"system":"sec-edgar","filing":"0001225208-24-005701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005701/doc4.xml","form_type":"4"}},{"id":1526663,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-05-06T23:17:52.000Z","date":"2024-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":291,"price":85.06,"value":24752.46,"ownership":{"direct":true},"balance_after":22459,"source":{"system":"sec-edgar","filing":"0001225208-24-005701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005701/doc4.xml","form_type":"4"}},{"id":1630673,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-02-21T22:52:11.000Z","date":"2024-02-21","kind":"exercise","planned":false,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001225208-24-002654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824002654/doc4.xml","form_type":"4"}},{"id":1630672,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-02-21T22:52:11.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":7000,"price":86.7525,"value":607267.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $86.7455 to $86.7600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22750,"source":{"system":"sec-edgar","filing":"0001225208-24-002654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824002654/doc4.xml","form_type":"4"}},{"id":1630671,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-02-21T22:52:11.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":1200,"price":86.6702,"value":104004.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $86.6600 to $86.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29750,"source":{"system":"sec-edgar","filing":"0001225208-24-002654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824002654/doc4.xml","form_type":"4"}},{"id":1630670,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2024-02-21T22:52:11.000Z","date":"2024-02-21","kind":"exercise","planned":false,"acquired":true,"shares":7000,"price":59.2567,"value":414796.9,"ownership":{"direct":true},"balance_after":30950,"source":{"system":"sec-edgar","filing":"0001225208-24-002654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824002654/doc4.xml","form_type":"4"}},{"id":1710074,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-12-15T22:22:12.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7000,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001225208-23-011152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011152/doc4.xml","form_type":"4"}},{"id":1710073,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-12-15T22:22:12.000Z","date":"2023-12-15","kind":"sale","planned":false,"acquired":false,"shares":7000,"price":78.2463,"value":547724.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $78.24 to $78.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23950,"source":{"system":"sec-edgar","filing":"0001225208-23-011152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011152/doc4.xml","form_type":"4"}},{"id":1710072,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-12-15T22:22:12.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":true,"shares":7000,"price":59.2567,"value":414796.9,"ownership":{"direct":true},"balance_after":30950,"source":{"system":"sec-edgar","filing":"0001225208-23-011152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011152/doc4.xml","form_type":"4"}},{"id":1720531,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-12-06T22:01:10.000Z","date":"2023-12-06","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14000,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001225208-23-010794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010794/doc4.xml","form_type":"4"}},{"id":1720530,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-12-06T22:01:10.000Z","date":"2023-12-06","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":70.0016,"value":245005.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $70.00 to $70.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23950,"source":{"system":"sec-edgar","filing":"0001225208-23-010794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010794/doc4.xml","form_type":"4"}},{"id":1720529,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-12-06T22:01:10.000Z","date":"2023-12-06","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":59.2567,"value":207398.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023."}],"balance_after":27450,"source":{"system":"sec-edgar","filing":"0001225208-23-010794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010794/doc4.xml","form_type":"4"}},{"id":1768713,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-10-03T20:58:53.000Z","date":"2023-10-03","kind":"exercise","planned":true,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17500,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001225208-23-009259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823009259/doc4.xml","form_type":"4"}},{"id":1768712,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-10-03T20:58:53.000Z","date":"2023-10-03","kind":"sale","planned":true,"acquired":false,"shares":8500,"price":70,"value":595000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023."}],"balance_after":23950,"source":{"system":"sec-edgar","filing":"0001225208-23-009259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823009259/doc4.xml","form_type":"4"}},{"id":1768711,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-10-03T20:58:53.000Z","date":"2023-10-03","kind":"exercise","planned":true,"acquired":true,"shares":8500,"price":59.2567,"value":503681.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023."}],"balance_after":32450,"source":{"system":"sec-edgar","filing":"0001225208-23-009259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823009259/doc4.xml","form_type":"4"}},{"id":1787860,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-09-06T21:09:18.000Z","date":"2023-09-06","kind":"exercise","planned":true,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26000,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001225208-23-008737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008737/doc4.xml","form_type":"4"}},{"id":1787859,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-09-06T21:09:18.000Z","date":"2023-09-06","kind":"sale","planned":true,"acquired":false,"shares":8500,"price":76.0717,"value":646609.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $75.83 to $76.42. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23950,"source":{"system":"sec-edgar","filing":"0001225208-23-008737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008737/doc4.xml","form_type":"4"}},{"id":1787858,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-09-06T21:09:18.000Z","date":"2023-09-06","kind":"exercise","planned":true,"acquired":true,"shares":8500,"price":59.2567,"value":503681.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023."}],"balance_after":32450,"source":{"system":"sec-edgar","filing":"0001225208-23-008737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008737/doc4.xml","form_type":"4"}},{"id":1794509,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-08-29T21:31:23.000Z","date":"2023-08-29","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":76.6936,"value":115040.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $76.690 to $76.701. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23950,"source":{"system":"sec-edgar","filing":"0001225208-23-008545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008545/doc4.xml","form_type":"4"}},{"id":1894027,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Performance Rights","published_at":"2023-05-15T22:25:43.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 11, 2026. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 11, 2026. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":8100,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001225208-23-005914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005914/doc4.xml","form_type":"4"}},{"id":1894026,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-05-15T22:25:43.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":49900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":49900,"derivative":{"exercise_price":88.78,"exercise_date":"2024-05-11","expiration_date":"2030-05-10","underlying":"Common Stock","underlying_shares":49900},"source":{"system":"sec-edgar","filing":"0001225208-23-005914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005914/doc4.xml","form_type":"4"}},{"id":1894025,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-05-15T22:25:43.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":6475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":25450,"source":{"system":"sec-edgar","filing":"0001225208-23-005914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005914/doc4.xml","form_type":"4"}},{"id":1899921,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Performance Rights","published_at":"2023-05-09T23:49:59.000Z","date":"2023-05-07","kind":"exercise","planned":false,"acquired":false,"shares":3413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":937,"derivative":{"exercise_date":"2023-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":3413},"source":{"system":"sec-edgar","filing":"0001225208-23-005619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005619/doc4.xml","form_type":"4"}},{"id":1899920,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-05-09T23:49:59.000Z","date":"2023-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":967,"price":88.74,"value":85811.58,"ownership":{"direct":true},"balance_after":18975,"source":{"system":"sec-edgar","filing":"0001225208-23-005619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005619/doc4.xml","form_type":"4"}},{"id":1899919,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-05-09T23:49:59.000Z","date":"2023-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1822,"price":88.74,"value":161684.28,"ownership":{"direct":true},"balance_after":19942,"source":{"system":"sec-edgar","filing":"0001225208-23-005619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005619/doc4.xml","form_type":"4"}},{"id":1899918,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-05-09T23:49:59.000Z","date":"2023-05-07","kind":"exercise","planned":false,"acquired":true,"shares":3413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":21764,"source":{"system":"sec-edgar","filing":"0001225208-23-005619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005619/doc4.xml","form_type":"4"}},{"id":1904791,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-05-05T01:48:40.000Z","date":"2023-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":279,"price":88.1,"value":24579.9,"ownership":{"direct":true},"balance_after":18351,"source":{"system":"sec-edgar","filing":"0001225208-23-005431","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005431/doc4.xml","form_type":"4"}},{"id":1904790,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-05-05T01:48:40.000Z","date":"2023-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":281,"price":87.81,"value":24674.61,"ownership":{"direct":true},"balance_after":18630,"source":{"system":"sec-edgar","filing":"0001225208-23-005431","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005431/doc4.xml","form_type":"4"}},{"id":1952730,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-03-15T21:28:08.000Z","date":"2023-03-15","kind":"exercise","acquired":false,"shares":4435,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":4435},"source":{"system":"sec-edgar","filing":"0001225208-23-003978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003978/doc4.xml","form_type":"4"}},{"id":1952729,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-03-15T21:28:08.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":4435,"price":77.4662,"value":343562.597,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.20 to $77.67 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18911,"source":{"system":"sec-edgar","filing":"0001225208-23-003978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003978/doc4.xml","form_type":"4"}},{"id":1952728,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-03-15T21:28:08.000Z","date":"2023-03-15","kind":"exercise","acquired":true,"shares":4435,"price":45.2767,"value":200802.1645,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":23346,"source":{"system":"sec-edgar","filing":"0001225208-23-003978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003978/doc4.xml","form_type":"4"}},{"id":2014104,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-02-15T23:20:44.000Z","date":"2023-02-15","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4435,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001225208-23-002043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823002043/doc4.xml","form_type":"4"}},{"id":2014103,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-02-15T23:20:44.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":4000,"price":76.01,"value":304040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":18911,"source":{"system":"sec-edgar","filing":"0001225208-23-002043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823002043/doc4.xml","form_type":"4"}},{"id":2014102,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-02-15T23:20:44.000Z","date":"2023-02-15","kind":"exercise","acquired":true,"shares":4000,"price":45.2767,"value":181106.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":22911,"source":{"system":"sec-edgar","filing":"0001225208-23-002043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823002043/doc4.xml","form_type":"4"}},{"id":2054055,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-01-17T23:18:01.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8435,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001225208-23-000678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823000678/doc4.xml","form_type":"4"}},{"id":2054054,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-01-17T23:18:01.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":4000,"price":78,"value":312000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":18911,"source":{"system":"sec-edgar","filing":"0001225208-23-000678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823000678/doc4.xml","form_type":"4"}},{"id":2054053,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2023-01-17T23:18:01.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":4000,"price":45.2767,"value":181106.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":22911,"source":{"system":"sec-edgar","filing":"0001225208-23-000678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823000678/doc4.xml","form_type":"4"}},{"id":2085537,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-12-15T23:12:58.000Z","date":"2022-12-15","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12435,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001225208-22-012850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012850/doc4.xml","form_type":"4"}},{"id":2085536,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-12-15T23:12:58.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":4000,"price":74.8,"value":299200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":18911,"source":{"system":"sec-edgar","filing":"0001225208-22-012850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012850/doc4.xml","form_type":"4"}},{"id":2085535,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-12-15T23:12:58.000Z","date":"2022-12-15","kind":"exercise","acquired":true,"shares":4000,"price":45.2767,"value":181106.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":22911,"source":{"system":"sec-edgar","filing":"0001225208-22-012850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012850/doc4.xml","form_type":"4"}},{"id":2116800,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-11-15T21:47:28.000Z","date":"2022-11-15","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16435,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001225208-22-011690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822011690/doc4.xml","form_type":"4"}},{"id":2116799,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-11-15T21:47:28.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":4000,"price":74.18,"value":296720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":18911,"source":{"system":"sec-edgar","filing":"0001225208-22-011690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822011690/doc4.xml","form_type":"4"}},{"id":2116798,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-11-15T21:47:28.000Z","date":"2022-11-15","kind":"exercise","acquired":true,"shares":4000,"price":45.2767,"value":181106.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":22911,"source":{"system":"sec-edgar","filing":"0001225208-22-011690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822011690/doc4.xml","form_type":"4"}},{"id":2137249,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-10-14T23:02:52.000Z","date":"2022-10-14","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20435,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001225208-22-010969","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822010969/doc4.xml","form_type":"4"}},{"id":2137248,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-10-14T23:02:52.000Z","date":"2022-10-14","kind":"sale","acquired":false,"shares":4000,"price":84.77,"value":339080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":18911,"source":{"system":"sec-edgar","filing":"0001225208-22-010969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822010969/doc4.xml","form_type":"4"}},{"id":2137247,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-10-14T23:02:52.000Z","date":"2022-10-14","kind":"exercise","acquired":true,"shares":4000,"price":45.2767,"value":181106.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022."}],"balance_after":22911,"source":{"system":"sec-edgar","filing":"0001225208-22-010969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822010969/doc4.xml","form_type":"4"}},{"id":2198133,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-08-03T00:23:30.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":1000,"price":102.49,"value":102490.0,"ownership":{"direct":true},"balance_after":18911,"source":{"system":"sec-edgar","filing":"0001225208-22-009141","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822009141/doc4.xml","form_type":"4"}},{"id":2255721,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-05-27T00:06:15.000Z","date":"2022-05-26","kind":"sale","acquired":false,"shares":1000,"price":98.3118,"value":98311.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $98.295 to $98.370. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19911,"source":{"system":"sec-edgar","filing":"0001225208-22-007410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007410/doc4.xml","form_type":"4"}},{"id":2268866,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-05-18T01:16:02.000Z","date":"2022-05-17","kind":"tax_withholding","acquired":false,"shares":1644,"price":95.93,"value":157708.92,"ownership":{"direct":true},"balance_after":20911,"source":{"system":"sec-edgar","filing":"0001225208-22-007135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007135/doc4.xml","form_type":"4"}},{"id":2276594,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Performance Rights","published_at":"2022-05-11T00:54:29.000Z","date":"2022-05-08","kind":"exercise","acquired":false,"shares":8531,"price":100.52,"value":857536.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":10968,"derivative":{"exercise_date":"2022-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":8531},"source":{"system":"sec-edgar","filing":"0001225208-22-006813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006813/doc4.xml","form_type":"4"}},{"id":2276593,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:29.000Z","date":"2022-05-08","kind":"tax_withholding","acquired":false,"shares":4469,"price":100.52,"value":449223.88,"ownership":{"direct":true},"balance_after":22555,"source":{"system":"sec-edgar","filing":"0001225208-22-006813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006813/doc4.xml","form_type":"4"}},{"id":2276592,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:29.000Z","date":"2022-05-08","kind":"exercise","acquired":true,"shares":8531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":27024,"source":{"system":"sec-edgar","filing":"0001225208-22-006813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006813/doc4.xml","form_type":"4"}},{"id":2276591,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:29.000Z","date":"2022-05-07","kind":"tax_withholding","acquired":false,"shares":305,"price":100.52,"value":30658.6,"ownership":{"direct":true},"balance_after":18493,"source":{"system":"sec-edgar","filing":"0001225208-22-006813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006813/doc4.xml","form_type":"4"}},{"id":2281152,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Performance Rights","published_at":"2022-05-05T21:51:30.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":4075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 3, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 3, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":4075,"derivative":{"exercise_date":"2025-05-03","underlying":"Common Stock","underlying_shares":4075},"source":{"system":"sec-edgar","filing":"0001225208-22-006581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006581/doc4.xml","form_type":"4"}},{"id":2281151,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-05-05T21:51:30.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":26400,"derivative":{"exercise_price":105.93,"exercise_date":"2023-05-03","expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001225208-22-006581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006581/doc4.xml","form_type":"4"}},{"id":2281150,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-05-05T21:51:30.000Z","date":"2022-05-04","kind":"tax_withholding","acquired":false,"shares":279,"price":105.93,"value":29554.47,"ownership":{"direct":true},"balance_after":18798,"source":{"system":"sec-edgar","filing":"0001225208-22-006581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006581/doc4.xml","form_type":"4"}},{"id":2281149,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2022-05-05T21:51:30.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":19077,"source":{"system":"sec-edgar","filing":"0001225208-22-006581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006581/doc4.xml","form_type":"4"}},{"id":2670714,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-06-15T01:21:24.000Z","date":"2021-06-14","kind":"exercise","acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24435,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001225208-21-009384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821009384/doc4.xml","form_type":"4"}},{"id":2670713,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2021-06-15T01:21:24.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":24000,"price":99.9579,"value":2398989.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $99.58 to $100.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15827,"source":{"system":"sec-edgar","filing":"0001225208-21-009384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821009384/doc4.xml","form_type":"4"}},{"id":2670712,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2021-06-15T01:21:24.000Z","date":"2021-06-14","kind":"exercise","acquired":true,"shares":24000,"price":45.2767,"value":1086640.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2021."}],"balance_after":39827,"source":{"system":"sec-edgar","filing":"0001225208-21-009384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821009384/doc4.xml","form_type":"4"}},{"id":2706207,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2021-05-19T20:31:28.000Z","date":"2021-05-17","kind":"tax_withholding","acquired":false,"shares":1146,"price":89.49,"value":102555.54,"ownership":{"direct":true},"balance_after":15827,"source":{"system":"sec-edgar","filing":"0001225208-21-008303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008303/doc4.xml","form_type":"4"}},{"id":2719256,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2021-05-11T21:14:33.000Z","date":"2021-05-07","kind":"tax_withholding","acquired":false,"shares":304,"price":91.75,"value":27892.0,"ownership":{"direct":true},"balance_after":16973,"source":{"system":"sec-edgar","filing":"0001225208-21-007972","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007972/doc4.xml","form_type":"4"}},{"id":2725450,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Performance Rights","published_at":"2021-05-07T01:10:39.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":4025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 4, 2021 and scheduled to vest on May 4, 2024. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":4025,"derivative":{"exercise_date":"2024-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":4025},"source":{"system":"sec-edgar","filing":"0001225208-21-007704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007704/doc4.xml","form_type":"4"}},{"id":2725449,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-05-07T01:10:39.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":28000,"derivative":{"exercise_price":93.31,"exercise_date":"2022-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001225208-21-007704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007704/doc4.xml","form_type":"4"}},{"id":2725448,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, Surgical Structural Heart"}}],"security":"Common Stock","published_at":"2021-05-07T01:10:39.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":3225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":17277,"source":{"system":"sec-edgar","filing":"0001225208-21-007704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007704/doc4.xml","form_type":"4"}}],"next_cursor":"2021-05-07T01:10:39.000000Z,2725448"}